Keywords: fda, requests, data, schering, yasmin, dupont, pharmaceuticals
FDA requests more data for Schering's Yasmin
Article | 20 July 2000
DuPont Pharmaceuticals has gained US Food and Drug Administrationbacking to market its once-daily low-molecular-weight heparin Innohep (tinzaparin sodium for injection). ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
